Tags: neurotransmitter, GABA, glutamate, acetylcholine, dopamine, serotonin, ionotropic receptors, metabotropic receptors, GPCR, G-protein coupled receptor, cAMP, adenylate cyclase, TTX, tetrodotoxin, caffeine, adenosine, cocaine, blood-brain barrier, BBB, Otto Loewi, Vagusstoff, agonist, antagonist, reuptake
Neurotransmitters are the chemical messengers of the nervous system, released at synapses to excite or inhibit the postsynaptic cell. They act on two broad receptor classes: ionotropic (fast, direct ion-channel opening) and metabotropic/GPCR (slower, secondary-messenger cascades). Pharmacology exploits these systems, with drugs like TTX blocking Na+ channels, caffeine blocking adenosine receptors, and cocaine blocking dopamine reuptake. The blood-brain barrier determines which substances can reach the brain.
GABA (gamma-aminobutyric acid)
The principal inhibitory neurotransmitter in the brain. Synthesised from glutamate by the enzyme glutamic acid decarboxylase (GAD).
Glutamate
The principal excitatory neurotransmitter in the brain. Also the biochemical precursor to GABA.
Glutamic acid decarboxylase (GAD)
The enzyme that converts glutamate into GABA. A key biosynthetic step linking the brain's main excitatory and inhibitory transmitters.
Acetylcholine (ACh)
A neurotransmitter involved in muscle contraction, autonomic function, and certain brain circuits. Identified as "Vagusstoff" in Otto Loewi's classic experiment.
Otto Loewi's frog heart experiment
Loewi stimulated the vagus nerve of one frog heart, collected the surrounding fluid, and applied it to a second heart. The second heart slowed, proving that a chemical substance (not just electrical impulses) mediated the signal. He called it "Vagusstoff," later identified as acetylcholine.
Vagusstoff
Otto Loewi's name for the substance released by the vagus nerve. Identified as acetylcholine.
Dopamine
A neurotransmitter involved in reward, motivation, and motor control. The target of many drugs of abuse and therapeutic agents.
Serotonin (5-HT)
A neurotransmitter involved in mood regulation, sleep, and appetite. Targeted by many antidepressants (SSRIs).
Ionotropic receptor (ligand-gated ion channel)
A receptor that is itself an ion channel. When the neurotransmitter binds, the channel opens directly, allowing ions to flow. Produces fast responses (EPSPs or IPSPs within milliseconds).
Metabotropic receptor (GPCR, G-protein coupled receptor)
A receptor that does not contain an ion channel. Instead, neurotransmitter binding activates an associated G-protein, which in turn activates effector enzymes and secondary messenger cascades. Produces slower, longer-lasting, and more diverse effects.
G-protein
A membrane-associated protein that acts as a molecular switch. When activated by a GPCR, it dissociates and interacts with effector enzymes.
Effector enzyme (e.g., adenylate cyclase)
An enzyme activated by the G-protein. Adenylate cyclase converts ATP into cyclic AMP (cAMP), a secondary messenger that triggers downstream intracellular effects.
cAMP (cyclic adenosine monophosphate)
A secondary messenger produced by adenylate cyclase. Amplifies the signal inside the cell, leading to effects such as phosphorylation cascades, changes in gene transcription, or modulation of ion channels.
EPSP (excitatory postsynaptic potential)
A small depolarisation of the postsynaptic membrane caused by excitatory neurotransmitter action (e.g., Na+ influx through ionotropic receptors).
IPSP (inhibitory postsynaptic potential)
A small hyperpolarisation of the postsynaptic membrane caused by inhibitory neurotransmitter action (e.g., Cl- influx through ionotropic receptors).
Agonist
A substance that binds to a receptor and activates it, mimicking the natural neurotransmitter's effect.
Antagonist
A substance that binds to a receptor and blocks it, preventing the natural neurotransmitter from producing its effect.
Tetrodotoxin (TTX)
A potent neurotoxin found in pufferfish. Blocks the pore of voltage-gated Na+ channels, preventing action potentials. Causes peripheral paralysis (especially respiratory muscles) but does not cross the blood-brain barrier, so the brain remains unaffected and the person stays conscious.
Caffeine
A psychoactive stimulant that acts as an antagonist at adenosine receptors. Since adenosine normally has an inhibitory, sleep-promoting effect, blocking it produces a net excitatory (stimulant) result.
Adenosine
An endogenous inhibitory neuromodulator. Accumulates during waking hours and promotes drowsiness. Caffeine blocks its receptors.
Cocaine
A stimulant that crosses the blood-brain barrier (it is lipophilic) and blocks the reuptake of dopamine (and other monoamines) in the synapse, prolonging and amplifying dopaminergic signalling.
Blood-brain barrier (BBB)
A regulatory boundary formed by tightly joined blood vessel cells in the CNS, with no gaps or pores. Only lipophilic molecules or those with specific transporters can cross. Protects the brain from many circulating toxins and pathogens.
Glutamate is the main excitatory transmitter; GABA is the main inhibitory transmitter.
GAD (glutamic acid decarboxylase) converts glutamate directly into GABA.
This means the same amino acid precursor feeds both the excitatory and inhibitory arms of brain signalling.
Before Loewi, it was debated whether neural communication was purely electrical or involved chemicals.
By transferring fluid from a vagus-stimulated heart to a second heart and observing the same slowing effect, Loewi demonstrated chemical transmission.
The substance, Vagusstoff, was later identified as acetylcholine.
Ionotropic: the receptor is the channel. Neurotransmitter binds, channel opens, ions flow. Fast (milliseconds). Produces direct EPSPs or IPSPs. Examples: nicotinic ACh receptors, GABA-A receptors, AMPA/NMDA glutamate receptors.
Metabotropic (GPCR): no channel in the receptor. Binding activates a G-protein, which activates an effector enzyme (e.g., adenylate cyclase), which produces a secondary messenger (e.g., cAMP). Slower (seconds to minutes). Effects are diverse: can open distant ion channels, alter gene transcription, or change metabolism. Examples: muscarinic ACh receptors, many dopamine and serotonin receptor subtypes.
Neurotransmitter binds the seven-transmembrane GPCR.
The associated G-protein is activated and dissociates.
The G-protein alpha subunit interacts with an effector enzyme (e.g., adenylate cyclase).
Adenylate cyclase converts ATP to cAMP.
cAMP triggers downstream effects (protein kinase activation, ion channel modulation, gene transcription changes).
This cascade allows signal amplification: one receptor binding event can produce a large intracellular response.
TTX: blocks voltage-gated Na+ channels in the periphery. Not lipophilic enough to cross the BBB and lacks a transporter, so the brain is spared. The person remains conscious while peripheral muscles (including respiratory muscles) are paralysed.
Caffeine: an adenosine receptor antagonist. Adenosine is inhibitory, so blocking it produces a stimulant effect. Caffeine does cross the BBB.
Cocaine: lipophilic, crosses the BBB readily. Blocks dopamine reuptake transporters, leading to elevated dopamine in the synapse and strong stimulant or euphoric effects.
The BBB is formed by endothelial cells joined tightly with no gaps.
Two main routes across: being sufficiently lipophilic (dissolving through the lipid membrane) or having a specific transporter protein.
Large, polar, or charged molecules generally cannot cross unless they have a dedicated transport mechanism.
⚠️ GABA is synthesised from glutamate by GAD. This is a directly tested fact. Do not confuse the direction (glutamate to GABA, not the reverse).
⚠️ Vagusstoff = acetylcholine. The exam uses the historical name.
⚠️ TTX blocks voltage-gated Na+ channels (not nicotinic receptors, not GABA receptors, not dopamine reuptake). And it does not cross the BBB.
⚠️ Caffeine is an adenosine receptor antagonist (not a dopamine, GABA, or opioid receptor antagonist).
⚠️ The function of adenylate cyclase in the GPCR pathway is to synthesise cAMP from ATP. It does not directly open ion channels or reabsorb neurotransmitter.
⚠️ Ionotropic = fast, direct channel. Metabotropic = slow, G-protein cascade. This comparison appears in both short-answer and multiple-choice formats.
Q: Which neurotransmitter is synthesised from glutamate by GAD?
A: GABA (gamma-aminobutyric acid).
Q: What was Vagusstoff, and who discovered it?
A: Vagusstoff was Otto Loewi's name for the chemical released by the vagus nerve that slowed the heart. It was later identified as acetylcholine.
Q: How does TTX work, and why does it not affect the brain?
A: TTX blocks voltage-gated Na+ channels, preventing action potentials in peripheral neurons. It cannot cross the blood-brain barrier because it is not lipophilic enough and lacks a dedicated transporter, so the brain is unaffected.
Q: How does caffeine produce its stimulant effect?
A: Caffeine is an antagonist at adenosine receptors. Since adenosine is normally inhibitory (promoting drowsiness), blocking it produces a net excitatory or stimulant effect.
Q: Compare ionotropic and metabotropic receptors.
A: Ionotropic receptors are ligand-gated ion channels that open directly when a neurotransmitter binds, producing fast changes in membrane potential (EPSPs or IPSPs). Metabotropic receptors (GPCRs) activate G-proteins and secondary messenger cascades (e.g., adenylate cyclase producing cAMP), producing slower but longer-lasting and more diverse effects including gene transcription changes.
Q: What is the function of adenylate cyclase in the GPCR pathway?
A: Adenylate cyclase is an effector enzyme that converts ATP into cAMP, a secondary messenger. This amplifies the signal and triggers downstream intracellular effects.
Q: Why can cocaine affect the brain but TTX cannot?
A: Cocaine is lipophilic and can dissolve through the blood-brain barrier to reach brain synapses. TTX is not sufficiently lipophilic and has no transporter, so it cannot cross the BBB.
neurotransmitter, GABA, glutamate, glutamic acid decarboxylase, GAD, acetylcholine, Vagusstoff, Otto Loewi, dopamine, serotonin, ionotropic receptor, ligand-gated ion channel, metabotropic receptor, GPCR, G-protein coupled receptor, G-protein, adenylate cyclase, cAMP, secondary messenger, EPSP, IPSP, agonist, antagonist, tetrodotoxin, TTX, caffeine, adenosine, cocaine, reuptake inhibitor, blood-brain barrier, BBB, lipophilic, transporter, MCB C61, Brain-Mind Odyssey